Onco-Innovations Limited (CVE:ONCO) | WebDisclosure

Basculer en Français

10678	Companies
227876	Keywords
156310	Articles
120753	Press releases

Headlines Articles Press releases Onco-Innovations Limited

Home
Companies
Onco-Innovations Limited

BRIEF

published on 07/01/2026 at 01:05, 2 days 9 hours ago

Onco-Innovations annonce un accord de financement de 5 millions de dollars canadiens

Accord De Financement Onco-Innovations Offre Privée Placement Sans Intermédiaire Bons De Souscription De Titres
BRIEF

published on 07/01/2026 at 01:05, 2 days 9 hours ago

Onco-Innovations Announces CAD$5 Million Funding Arrangement

Private Offering Funding Arrangement Onco-Innovations Non-Brokered Placement Securities Warrants
PRESS RELEASE

published on 07/01/2026 at 01:00, 2 days 9 hours ago

Onco-Innovations Announces Term Sheet for Notional CAD$5 Million Performance-Based Funding Arrangement and Amendments to Previously Announced Financing
Onco-Innovations Limited announces non-brokered private placement financing for CAD$5,000,000 with institutional investors. Offering consists of 6,764,070 units at CAD$0.7392/unit. Expected closing on July 15, 2026

Private Placement Financing Institutional Investors Non-brokered Onco-Innovations Limited CAD$5,000,000
BRIEF

published on 07/01/2026 at 00:05, 2 days 10 hours ago

Onco-Innovations lance un procédé polymère clé pour ONC010

Développement Thérapeutique Onco-Innovations Nanopolymères Souples NOP010 Procédé De Polymérisation
BRIEF

published on 07/01/2026 at 00:05, 2 days 10 hours ago

Onco-Innovations Launches Key Polymer Process for ONC010

Therapeutic Development Onco-Innovations Nanosoft Polymers Polymer Process NOP010
PRESS RELEASE

published on 07/01/2026 at 00:00, 2 days 10 hours ago

Onco-Innovations Initiates Polymer Process Development and Characterization Program for ONC010
Onco-Innovations announces polymer process development and analytical characterization activities for ONC010 nanoparticle inhibitor in collaboration with Nanosoft, strengthening future GMP manufacturing and clinical development

Onco-Innovations ONC010 Polymer Process Development Analytical Characterization Nanosoft
BRIEF

published on 06/27/2026 at 00:05, 6 days 10 hours ago

Onco-Innovations Initiates Metabolic Studies for ONC010

Drug Development Preclinical Studies Onco-Innovations ONC010 Liver Metabolism
BRIEF

published on 06/27/2026 at 00:05, 6 days 10 hours ago

Onco-Innovations lance des études métaboliques pour ONC010

Développement De Médicaments Etudes Précliniques Onco-Innovations ONC010 Métabolisme Hépatique
PRESS RELEASE

published on 06/27/2026 at 00:00, 6 days 10 hours ago

Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Onco-Innovations announces hepatocyte and liver microsome metabolism studies for ONC010, its lead nanoparticle-formulated PNKP inhibitor, to support future toxicology studies and regulatory submissions

Metabolism Onco-Innovations ONC010 Hepatocyte Liver Microsome
BRIEF

published on 06/24/2026 at 00:05, 9 days 10 hours ago

Onco-Innovations Partners with Nanosoft for ONC010 Development

Drug Delivery Onco-Innovations ONC010 Nanosoft Polymers Polymer Development

Accesswire

Published on 07/03/2026 at 00:45, 9 hours 56 minutes ago

FireFox Gold Finalizes Finders Fees on Recent Offering
Published on 07/03/2026 at 00:05, 10 hours 36 minutes ago

Update to Tintina Mines Previous Announcement on June 2, 2026 of a C$91 Million Private Placement and Strategic Partnership with the Gignac Family and Sumitomo Corporation for the Development of the Domeyko Sulfuros Copper-Gold Project in Chile
Published on 07/03/2026 at 00:00, 10 hours 41 minutes ago

Redwood AI Added to CSE25 Index as One of the Largest Companies Listed on the Canadian Securities Exchange
Published on 07/02/2026 at 23:05, 11 hours 36 minutes ago

AI/ML Innovations Announces Completion of Share Issuance
Published on 07/02/2026 at 19:45, 14 hours 56 minutes ago

Infield Minerals Issues Shares for Kings Canyon Gold Property Option Payment

View all ACCESSWIRE

EQS Group

Published on 07/03/2026 at 10:03, 37 minutes ago

Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech
Published on 07/03/2026 at 10:03, 37 minutes ago

Sartorius Stedim Biotech SA: Bilan semestriel du contrat de liquidité de la société Sartorius Stedim Biotech
Published on 07/03/2026 at 09:00, 1 hour 40 minutes ago

Original-Research: HausVorteil AG (von NuWays AG): BUY
Published on 07/03/2026 at 09:00, 1 hour 40 minutes ago

Original-Research: LION E-Mobility AG (von NuWays AG): BUY
Published on 07/03/2026 at 09:00, 1 hour 41 minutes ago

Official List Notice

Les Echos

Published on 07/03/2026 at 10:21, 20 minutes ago

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
Published on 07/03/2026 at 09:33, 1 hour 7 minutes ago

BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE
Published on 07/02/2026 at 18:33, 16 hours 7 minutes ago

Annonce des principales caractéristiques d'un projet d'offre publique de retrait et désignation expert financier
Published on 07/02/2026 at 18:28, 16 hours 12 minutes ago

Emova Group - Résultats 1er semestre 2025/26
Published on 07/02/2026 at 18:00, 16 hours 41 minutes ago

Publication du nombre d’actions composant le capital et du nombre total de droits de vote au 30 juin 2026

View all LES ECHOS COMFI WIRE